Consistent with AIM assay results, there was a significant increase in spike-specific CD4+ tetramer+ T cells but not spike-specific CD8+ tetramer+ T cells in 10 patients with BT infection by TAME assay (Figure 4D). This evidence concerns the gene CD8A and infection.